The latter two genes were also found to have a prognostic value in pancreatic cancer patients, since Kaplan–Meier survival analysis showed that subjects with low expression of ANLN and TRPS1 were associated with a longer survival than those with high levels (p < 0.0001 and p = 0.0039, respectively, by log-rank Mantel–Cox test) (Figure 1D). The gene discussed is ANLN; the disease is pancreatic neoplasm.